Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells

International Journal of Molecular Medicine

Volumn 17, Issue 3, 2006, Pages 457-463

  Mewani, Rajshree R ^a   Song, Tian ^a   Li, Bihua ^a   Danner, Malika T ^a   Carr, Theresa D ^a   Lee, Sung ^a   Rahman, Aquilur ^a   Kasid, Usha N ^a   Jung, Mira ^a   Dritschilo, Anatoly ^a   Gokhale, Prafulla C ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Antisense oligonucleotide; Breast cancer cells; Microarray; Raf 1

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; RAF PROTEIN;

ARTICLE; BREAST TUMOR; CELL CULTURE; DNA MICROARRAY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NORTHERN BLOTTING; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-RAF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33644942681     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.3.457     Document Type: Article

References (43)

1. Kolch W, Heidecker G, Lloyd P and Rapp UR: Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349: 426-428, 1991.
2. Kasid U, Suy S, Dent P, Ray S, Whiteside TL and Sturgill TW: Activation of Raf by ionizing radiation. Nature 382: 813-816, 1996.
3. Bruder JT, Heidecker G and Rapp UR: Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev 6: 545-556, 1992.
4. Janknecht R, Ernst WH, Pingoud V and Nordheim A: Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J 12: 5097-5104, 1993.
5. Finco TS and Baldwin AS: Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. J Biol Chem 268: 17676-17679, 1993.
6. Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M and McCormick F: Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 103: 321-330, 2000.
7. Patel S, Wang FH, Whiteside TL and Kasid U: Constitutive modulation of Raf-1 protein kinase is associated with differential gene expression of several known and unknown genes. Mol Med 3: 674-685, 1997.
8. Schulze A, Lehmann K, Jefferies HB, McMahon M and Downward J: Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev 15: 981-994, 2001.
9. Morrison DK and Cutler RE: The complexity of Raf-1 regulation. Curr Opin Cell Biol 9: 174-179, 1997.
10. Hindley A and Kolch W: Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. J Cell Sci 115: 1575-1581, 2002.
11. Huser M, Luckett J, Chiloeches A, Mercer K, Iwobi M, Giblett S, Sun XM, Brown J, Marais R and Pritchard C: MEK kinase activity is not necessary for Raf-1 function. EMBO J 20: 1940-1951, 2001.
12. Mikula M, Schreiber M, Husak Z, Kucerova L, Ruth J, Wieser R, Zatloukal K, Beug H, Wagner EF and Baccarini M: Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J 20: 1952-1962, 2001.
13. Wang HG, Rapp UR and Reed J: Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87: 629-638, 1996.
14. Li S and Sedivy JM: Raf-1 protein kinase activates the NF-kappa B transcription factor by dissociating the cytoplasmic NF-kappa B-I kappa B complex. Proc Natl Acad Sci USA 90: 9247-9251, 1993.
15. Micheau O, Lens S, Gaide O, Alevizopoulos K and Tschopp J: NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21: 5299-5305, 2001.
16. Baumann B, Weber CK, Troppmair J, Whiteside S, Israel A, Rapp UR and Wirth T: Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc Natl Acad Sci USA 97: 4615-4620, 2000.
17. Kasid U, Pfeifer A, Brennan T, Beckett M, Weichselbaum RR, Dritschilo A and Mark GE: Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science 243: 1354-1356, 1989.
18. Rasouli-Nia A, Liu D, Perdue S and Britten RA: High Raf-1 kinase activity protects human tumor cells against paclitaxel-induced cytotoxicity. Clin Cancer Res 4: 1111-1116, 1998.
19. Weinstein-Oppenheimer CR, Henriquez-Roldan CF, Davis JM, Navolanic PM, Saleh OA, Steelman LS, Franklin RA, Robinson PJ, McMahon M and McCubrey JA: Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. Clin Cancer Res 7: 2898-2907, 2001.
20. Monia BP, Johnston JF, Geiger T, Muller M and Fabbro D: Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med 2: 668-675, 1996.
21. Gokhale PC, McRae D, Monia BP, Bagg A, Rahman A, Dritschilo A and Kasid U: Antisense raf oligodeoxyribonucleotide is a radiosensitizer in vivo. Antisense Nucleic Acid Drug Dev 9: 191-201, 1999.
22. Gokhale PC, Zhang C, Newsome JT, Pei J, Ahmad I, Rahman A, Dritschilo A and Kasid U: Pharmacokinetics, toxicity, and efficacy of ends-modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic liposome. Clin Cancer Res 8: 3611-3621, 2002.
23. Mewani RR, Tang W, Rahman A, Dritschilo A, Ahmad I, Kasid UN and Gokhale PC: Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models. Int J Oncol 24: 1181-1188, 2004.
24. Lau QC, Brusselbach S and Muller R: Abrogation of c-Raf expression induces apoptosis in tumor cells. Oncogene 16: 1899-1902, 1998.
25. Slater EP, Stubig T, Lau QC, Achenbach TV, Rapp UR and Muller R: C-Raf controlled pathways in the protection of tumor cells from apoptosis. Int J Cancer 104: 425-432, 2003.
26. Sambrook J and Russell DW: Molecular Cloning: a Laboratory Manual. 3rd edition. Cold Spring Harbor Laboratory Press, New York, 2001.
27. Fisher AA, Ye D, Sergueev DS, Fisher MH, Shaw BR and Juliano RL: Evaluating the specificity of antisense oligonucleotide conjugates. A DNA array analysis. J Biol Chem 277: 22980-22984, 2002.
28. Janosch P, Kieser A, Eulitz M, Lovric J, Sauer G, Reichert M, Gounari F, Buscher D, Baccarini M, Mischak H and Kolch W: The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments. FASEB J 14: 2008-2021, 2000.
29. Broustas CG, Grammatikakis N, Eto M, Dent P, Brautigan DL and Kasid U: Phosphorylation of the myosin-binding subunit of myosin phosphatase by Raf-1 and inhibition of phosphatase activity. J Biol Chem 277: 3053-3059, 2002.
30. Turner CE: Paxillin and focal adhesion signaling. Nat Cell Biol 2: E231-E236, 2000.
31. Ishibe S, Joly D, Zhu X and Cantley LG: Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. Mol Cell 12: 1275-1285, 2003.
32. Wiche G: Role of plectin in cytoskeleton organization and dynamics. J Cell Sci 111: 2477-2486, 1998.
33. Stegh AH, Herrmann H, Lampel S, Weisenberger D, Andra K, Seper M, Wiche G, Krammer PH and Peter ME: Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol Cell Biol 20: 5665-5679, 2000.
34. Sasaki T and Takai Y: The Rho small G protein family-Rho GDI system as a temporal and spatial determinant for cytoskeletal control. Biochem Biophys Res Commun 245: 641-645, 1998.
35. MacKeigan JP, Clements CM, Lich JD, Pope RM, Hod Y and Ting JP: Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res 63: 6928-6934, 2003.
36. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB and von Hoff DD: Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 62: 2890-2896, 2002.
37. Shimizu S, Narita M and Tsujimoto Y: Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487, 1999.
38. Le Mellay V, Troppmair J, Benz R and Rapp UR: Negative regulation of mitochondrial VDAC channels by C-Raf kinase. BMC Cell Biol 3: 14-25, 2002.
39. Le Mellay V, Houben R, Troppmair J, Hagemann C, Mazurek S, Frey U, Beigel J, Weber C, Benz R, Eigenbrodt E and Rapp UR: Regulation of glycolysis by Raf protein serine/threonine kinases. Adv Enzyme Regul 42: 317-332, 2002.
40. Shimada S, Shiomori K, Tashima S, Tsuruta J and Ogawa M: Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas. Br J Cancer 84: 1497-1504, 2001.
41. Shimada S, Tashima S, Yamaguchi K, Matsuzaki H and Ogawa M: Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase. J Exp Clin Cancer Res 1: 111-118, 1999.
42. Wilson MC, Jackson VN, Heddle C, Price NT, Pilegaard H, Juel C, Bonen A, Montgomery I, Hutter OF and Halestrap AP: Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter isoform MCT3. J Biol Chem 273: 15920-15926, 1998.
43. Munoz-Pinedo C, Ruiz-Ruiz C, Ruiz de Almodovar C, Palacios C and Lopez-Rivas A: Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing. J Biol Chem 278: 12759-12768, 2003.